Akbari, Abolfazl <br/><br/>
Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma.  [electronic resource] 

 -  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences  Jun 2014 
 - 47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2008-2231 
<br/><br/><label>Standard No.: </label>10.1186/2008-2231-22-47  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colonic Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Neovascularization, Pathologic--metabolism<br/>Pteridines--pharmacology<br/>Transforming Growth Factor beta--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays